Announcements

06.12.2019

Trace amounts of a nitrosamine impurity found in individual diabetes medicines

Isolated traces of the nitrosamine NDMA have been detected in individual diabetes preparations with the active substance metformin – investigations are ongoing worldwide.

03.12.2019

13 new psychoactive substances added to Narcotics List

FDHA has prompted to add substances to the Narcotics List to combat drug trafficking

29.11.2019

Aufsichtsabgabe 2019 – Selbstdeklaration

Eingabefrist: 24. Januar 2020

22.11.2019

Potential nitrosamine contamination: request to perform a risk evaluation

Marketing authorisation holders of human medicinal products asked to conduct their own evaluation of the potential risk of contamination with nitrosamines.

28.10.2019

Intensified action targeting illegally imported erectile stimulants: what they really contain

Swissmedic laboratory inspects illegal shipments of medicinal products in which tadalafil is the declared active substance

22.10.2019

Warning regarding Esillaa slimmers’ tea

Swissmedic is issuing a warning regarding the slimming product Esillaa.

30.09.2019

Fixed texts for medicinal products which are being reallocated from dispensing category C to B as of 2019

Adaptation of fixed texts for medicinal products that may continue to be dispensed by pharmacies without a medical prescription after expert advice.

27.09.2019

Training course for regulatory authorities in low- and middle-income countries

Regulatory Training Workshops – a partnership for better health

26.09.2019

Anti-rabies vaccines: Supply problems until at least 2020

Temporary modification of the vaccine recommendations by the FOPH

23.09.2019

Recall of all preparations containing ranitidine from the Swiss market

Gastric acid blocker contaminated with traces of NDMA – use available alternative treatments for this indication.

06.12.2019

Trace amounts of a nitrosamine impurity found in individual diabetes medicines

Isolated traces of the nitrosamine NDMA have been detected in individual diabetes preparations with the active substance metformin – investigations are ongoing worldwide.

03.12.2019

13 new psychoactive substances added to Narcotics List

FDHA has prompted to add substances to the Narcotics List to combat drug trafficking

29.11.2019

Aufsichtsabgabe 2019 – Selbstdeklaration

Eingabefrist: 24. Januar 2020

22.11.2019

Potential nitrosamine contamination: request to perform a risk evaluation

Marketing authorisation holders of human medicinal products asked to conduct their own evaluation of the potential risk of contamination with nitrosamines.

28.10.2019

Intensified action targeting illegally imported erectile stimulants: what they really contain

Swissmedic laboratory inspects illegal shipments of medicinal products in which tadalafil is the declared active substance

22.10.2019

Warning regarding Esillaa slimmers’ tea

Swissmedic is issuing a warning regarding the slimming product Esillaa.

30.09.2019

Fixed texts for medicinal products which are being reallocated from dispensing category C to B as of 2019

Adaptation of fixed texts for medicinal products that may continue to be dispensed by pharmacies without a medical prescription after expert advice.

27.09.2019

Training course for regulatory authorities in low- and middle-income countries

Regulatory Training Workshops – a partnership for better health

26.09.2019

Anti-rabies vaccines: Supply problems until at least 2020

Temporary modification of the vaccine recommendations by the FOPH

23.09.2019

Recall of all preparations containing ranitidine from the Swiss market

Gastric acid blocker contaminated with traces of NDMA – use available alternative treatments for this indication.

Last modification 16.11.2017

Top of page